Forum Markets Incorporated (FRMM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting will be held virtually on December 27, 2024, to vote on key proposals including director elections, amendments to the incentive plan, executive compensation, major share issuances, and auditor ratification.
Shareholders of record as of October 31, 2024, are eligible to vote, with 1,976,999 voting shares outstanding.
The Board unanimously recommends voting in favor of all proposals.
Voting matters and shareholder proposals
Election of three Class II directors for two-year terms: Blair Jordan, Ryan Smith, and Omar Jimenez.
Approval of the Third Amendment to the 2022 Omnibus Incentive Plan, increasing the share reserve to 1,000,000 shares.
Advisory vote on named executive officer compensation (say-on-pay).
Approval of the issuance of more than 20% of outstanding common stock upon conversion of Series B Convertible Preferred Stock and upon exercise of warrants, in compliance with Nasdaq rules.
Ratification of M&K CPAs, PLLC as independent auditors for fiscal year 2024.
Board of directors and corporate governance
The Board consists of five directors, divided into two classes with staggered two-year terms.
All current committee members are independent under Nasdaq standards.
Board committees include Audit, Compensation, Nominating and Corporate Governance, and Strategy and Alternatives, Risk, Safety and Regulatory.
Board diversity matrix disclosed; currently no diverse directors, but future appointments will consider diversity.
Latest events from Forum Markets Incorporated
- Tokenizing real-world assets on Ethereum unlocks high-yield, compliant investment opportunities.FRMM
Investor presentation20 Mar 2026 - Tokenizing real-world assets for yield, with rapid expansion and institutional focus.FRMM
Sidoti March Small-Cap Virtual Conference18 Mar 2026 - Tokenizing real-world assets for high-yield, compliant DeFi access and institutional adoption.FRMM
Investor presentation23 Jan 2026 - Registers 2.7M shares for resale amid DeFi expansion, ETH exposure, and high financial risk.FRMM
Registration Filing18 Dec 2025 - Registering 752,873 shares for resale as company pivots from biotech to blockchain iGaming.FRMM
Registration Filing16 Dec 2025 - Transitioning to blockchain iGaming, raising up to $500M for growth and strategic initiatives.FRMM
Registration Filing16 Dec 2025 - Shareholders to vote on director, equity plans, cap removal, and share increase proposals.FRMM
Proxy Filing2 Dec 2025 - Stockholders will vote on director elections, equity plan expansion, major stock issuances, and auditor ratification.FRMM
Proxy Filing2 Dec 2025 - Shareholders to vote on director election, equity plans, and major capital structure amendments.FRMM
Proxy Filing2 Dec 2025